|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2000; 35:563-568 © 2000 by the American College of Cardiology Foundation |
* Department of Cardiology, National Heart Centre, Singapore
Department of Cardiology, Joseph J. Jacobs for Thrombosis and Vascular Biology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Manuscript received June 22, 1999; revised manuscript received October 25, 1999, accepted November 17, 1999.
Reprint requests and correspondence: Dr. Eric J. Topol, Department of Cardiology, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195
topole{at}ccf.org
Although fibrinolysis has improved survival of patients after myocardial infarction (MI), such therapy is less likely to be administered to patients with diabetes. Furthermore, these patients present later (15 min) than nondiabetics. Moreover, even with the use of early potent fibrinolytic agents, patients with diabetes continued to suffer excessive morbidity and mortality. This finding is not related to the ability of fibrinolytic agents to restore complete reperfusion or increased risk of reocclusion of the infarct-related artery. Instead, the impaired ventricular performance at the noninfarct areas and metabolic derangements during the acute phase of MI may account for the adverse outcome. The efficacy of percutaneous coronary revascularization procedures for treatment of acute MI requires further evaluation. Therapeutic approaches should consider correcting these abnormalities to afford greater survival benefit for this subset of high-risk patients.
| ||||||||||||||||||||||
This article has been cited by other articles:
|
|
 |
|
  A. G. Rosenfeld State of the Heart: Building Science to Improve Women's Cardiovascular Health Am. J. Crit. Care., November 1, 2006; 15(6): 556 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Kvan, A Reikvam, and INPHAR Study Investigators Thrombolytic treatment in diabetic patients with acute myocardial infarction: lower rates of use than in non-diabetic patients are explained by differences in presenting ECGs Heart, November 1, 2004; 90(11): 1346 - 1347. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Franklin, R. J. Goldberg, F. Spencer, W. Klein, A. Budaj, D. Brieger, M. Marre, P. G. Steg, N. Gowda, J. M. Gore, et al. Implications of Diabetes in Patients With Acute Coronary Syndromes: The Global Registry of Acute Coronary Events Arch Intern Med, July 12, 2004; 164(13): 1457 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K H Mak, J D Kark, K S Chia, L L Sim, B H Foong, Z P Ding, R Kam, and S K Chew Ethnic variations in female vulnerability after an acute coronary event Heart, June 1, 2004; 90(6): 621 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Zairis, A. G. Lyras, S. S. Makrygiannis, P. K. Psarogianni, E. N. Adamopoulou, S. M. Handanis, A. Papantonakos, S. K. Argyrakis, A. A. Prekates, and S. G. Foussas Type 2 Diabetes and Intravenous Thrombolysis Outcome in the Setting of ST Elevation Myocardial Infarction Diabetes Care, April 1, 2004; 27(4): 967 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Brady and A. Jovanovic The sulfonylurea controversy: Much ado about nothing or cause for concern? J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1022 - 1025. [Full Text] [PDF]
|
|
|
|
 |
|
 I. L Williams, B. Noronha, and A. G Zaman Review: The management of acute myocardial infarction in patients with diabetes mellitus The British Journal of Diabetes & Vascular Disease, September 1, 2003; 3(5): 319 - 324. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Tikiz, U. Tezcan, M. Ileri, Y. Balbay, R. Atak, and E. Kutuk Diabetes Mellitus Adversely Affects the Outcomes of Thrombolytic Therapy in Patients with Acute Myocardial Infarction Angiology, July 1, 2003; 54(4): 449 - 456. [Abstract] [PDF]
|
|
|
|
 |
|
 J Sala, R Masia, F-J Gonzalez de Molina, J M Fernandez-Real, M Gil, D Bosch, W Ricart, M Senti, and J Marrugat Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission J. Epidemiol. Community Health, September 1, 2002; 56(9): 707 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L F Hsu, K H Mak, K W Lau, L L Sim, C Chan, T H Koh, S C Chuah, R Kam, Z P Ding, W S Teo, et al. Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis Heart, September 1, 2002; 88(3): 260 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. BOORD, A. L. GRABER, J. W. CHRISTMAN, and A. C. POWERS Practical Management of Diabetes in Critically Ill Patients Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1763 - 1767. [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Beller Coronary Heart Disease in the First 30 Years of the 21st Century: Challenges and Opportunities : The 33rd Annual James B. Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association Circulation, May 22, 2001; 103(20): 2428 - 2435. [Full Text] [PDF]
|
|
|
|
|
|
G. S FRANCIS Diabetic cardiomyopathy: fact or fiction? Heart, March 1, 2001; 85(3): 247 - 248. [Full Text]
|
|
|
|
 |
|
 C.-K Wong and H.D White Dithering over the treatment of diabetics with acute myocardial infarction Eur. Heart J., December 1, 2000; 21(23): 1907 - 1909. [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
